Legacy Capital Group California Inc. Sells 950 Shares of Koninklijke Philips (NYSE:PHG)

Legacy Capital Group California Inc. decreased its position in shares of Koninklijke Philips (NYSE:PHG) by 5.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,496 shares of the technology company’s stock after selling 950 shares during the period. Legacy Capital Group California Inc.’s holdings in Koninklijke Philips were worth $507,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of PHG. Kitching Partners LLC increased its stake in shares of Koninklijke Philips by 3.4% in the 2nd quarter. Kitching Partners LLC now owns 10,802 shares of the technology company’s stock valued at $272,000 after buying an additional 356 shares during the period. Bruce G. Allen Investments LLC boosted its holdings in Koninklijke Philips by 6.1% in the second quarter. Bruce G. Allen Investments LLC now owns 6,590 shares of the technology company’s stock valued at $166,000 after acquiring an additional 381 shares during the last quarter. Riverwater Partners LLC increased its position in Koninklijke Philips by 3.4% in the second quarter. Riverwater Partners LLC now owns 16,201 shares of the technology company’s stock worth $408,000 after purchasing an additional 534 shares during the period. Holderness Investments Co. raised its holdings in Koninklijke Philips by 3.4% during the 2nd quarter. Holderness Investments Co. now owns 16,807 shares of the technology company’s stock worth $424,000 after purchasing an additional 546 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Koninklijke Philips by 7.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 8,084 shares of the technology company’s stock valued at $204,000 after purchasing an additional 550 shares during the period. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Down 1.6 %

Shares of Koninklijke Philips stock opened at $31.67 on Friday. The business has a fifty day simple moving average of $31.05 and a 200 day simple moving average of $27.61. The stock has a market cap of $29.77 billion, a PE ratio of -59.75, a price-to-earnings-growth ratio of 1.05 and a beta of 0.74. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. Koninklijke Philips has a 12 month low of $18.06 and a 12 month high of $32.91.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. The company had revenue of $4.80 billion for the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. Research analysts predict that Koninklijke Philips will post 1.59 EPS for the current year.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research note on Monday, July 15th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Koninklijke Philips has an average rating of “Hold”.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.